PureTech Health (NASDAQ:PRTC) Stock Price Up 2.5% - What's Next?
PureTech Health (NASDAQ:PRTC) shares rose 2.5% to $18.25 during trading, with a notable increase in volume. A hedge fund, Millennium Management LLC, recently acquired 45,264 shares valued at approximately $823,000. The company is focused on developing biotechnology solutions, including treatments for idiopathic pulmonary fibrosis and solid tumors. Despite a Strong Buy rating, analysts suggest there are better investment options available.
PureTech Health plc (NASDAQ:PRTC - Get Free Report) rose 2.5% during trading on Monday . The stock traded as high as $18.53 and last traded at $18.25. Approximately 3,307 shares traded hands during mid-day trading, an increase of 30% from the average daily volume of 2,553 shares. The stock had previously closed at $17.80.
Get PureTech Health alerts:
PureTech Health Stock Up 2.5 %
The firm has a 50 day simple moving average of $18.55 and a 200 day simple moving average of $20.20.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in PureTech Health stock. Millennium Management LLC bought a new position in PureTech Health plc (NASDAQ:PRTC - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 45,264 shares of the company's stock, valued at approximately $823,000. Millennium Management LLC owned 0.19% of PureTech Health as of its most recent SEC filing. Institutional investors own 0.04% of the company's stock.
About PureTech Health
(Get Free Report)PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Featured Stories
- Five stocks we like better than PureTech Health
- How to start investing in penny stocks
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Short Selling: How to Short a Stock
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Market Cap Calculator: How to Calculate Market Cap
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in PureTech Health Right Now?
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
